To examine ERBIN's effect on TGF‐β‐induced EMT, we analyzed breast [23] and lung cancer patient [24] cohorts and found that ERBIN positively correlates with the epithelial marker CDH1 (encoding E‐Cadherin) and negatively correlates with the mesenchymal markers CDH2 (encoding N‐Cadherin) and SNAI1 (Supplementary Fig. S1A,B). Here, SNAI1 is linked to lung cancer.